Recital 12, Regulation (EU) 2023/1182

In forcesince 14 Jun 2023

Where the specific rules for the placing on the market in Northern Ireland of medicinal products for human use are suspended, the relevant provisions of Union law listed in Annex 2 to the Protocol should apply again to such medicinal products.